BSEOthers2d ago · 3 Sept 2026, 02:23 pm
Annual Report for the Financial year 2025-26
Gujarat Kidney and Super Speciality Ltd · 544666
✦ AI SummaryResults
Gujarat Kidney and Super Speciality Ltd has announced its Annual Report for the financial year 2025-26, along with the notice for the 7th Annual General Meeting to be held on September 28, 2026. The meeting will consider the adoption of audited financial statements, appointment of a director, and other business.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gujarat Kidney and Super Speciality Ltd - 544666 - Reg. 34 (1) Annual Report.
Attachments (1)
📄pdf
Download →
d9e6199f-8953-4fc0-b59c-ec51491c7a2f.pdf
View document text
GUJARAT KIDNEY &
SUPERSPECIALITY LIMITED
ANNUAL REPORT
2025–26
NEPHROLOGY • UROLOGY • ADVANCED CARE
Precision in every decision.
Compassion in every outcome.
Board of Directors Mr Pragnesh Bharpoda Executive Director
Mrs Bharti Pragnesh Executive Director
Bharpoda
Mrs Anita Naik Non Executive Director
Mr Jagdish Thakkar Non Executive
Independent Director
Mr Udayan Kachchi Non Executive
Independent Director
Mrs Kairavi Shah Non Executive
Independent Director
Mr. Paresh Dhoti* Non Executive
Independent Director
Mrs. Disha Bharpoda** Non Executive
Independent Director
Chief Financial Mrs Bhavika Patel
Officer
Company Secretary Mrs Vishakha Mahesh Phadke
Statutory Auditors Y M Shah & Associates
Registered Office Plot No.1, City survey 1537/A, Gokak Mill Compound,
Jetalpur Road, Alkapuri, Vadodara, Gujarat – 390020
Registrar and MUFG Intime India Private Limited
Transfer Agent
Note: * Appointed as Additional Director of the Company w.e.f. 14.08.2026, subject to
confirmation of shareholders
** Appointed as Additional Director of the Company w.e.f. 24.08.2026, subject to
confirmation of shareholders
Contents Page No.
1. Notice 1
2. Directors’ Report 26
3. Report on Corporate Governance 38
4. Annexures 53
Standalone Financial Statements
5. Independent Auditors’ Report 74
6. Financial Statements 90
Consolidated Financial Statements
7. Independent Auditors’ Report 133
8. Financial Statements 146
9. Attendance and Proxy Slip 200
10. Route Map 203
NOTICE
Notice is hereby given that the 7th Annual General Meeting of the Members of Gujarat
Kidney And Superspeciality Limited will be held on Monday, the 28th day of
September, 2026 at 9.30 a.m. at the Registered Office of the Company situated at Plot
No. 1, City Survey 1537/A, Jetalpur Road, Gokak Mill Compound, Alkapuri, Vadodara,
Gujarat – 390020, to transact the following business :-
ORDINARY BUSINESS:
1. Adoption of :
a) the audited Standalone Financial Statements of the Company for the financial year
ended on March 31, 2026 and the Reports of the Directors and the Auditors thereon
b) the audited Consolidated Financial Statements of the Company for the financial
year ended on March 31, 2026 and the Report of the Auditors thereon.
2. Appointment of a Director retiring by rotation.
To appoint a Director in place of Mrs. Anita Bharpoda (DIN: 08644747), who retires
by rotation and being eligible, offers her candidature for re-appointment.
SPECIAL BUSINESS:
3. Appointment of Secretarial Auditors
To consider and if thought fit, to pass, with or without modification(s), the following
resolution as an Ordinary Resolution:
“RESOLVED THAT pursuant to the provisions of Sections 179 and 204 and other
applicable provisions of the Companies Act, 2013, read with the rules made thereunder,
and Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, as amended from time to time, and based on the recommendations
of the Audit Committee and the Board of Directors, the approval of the members be and
is hereby accorded for the appointment of M/s SPANJ & Associates, Practicing Company
Secretaries, Ahmedabad as Secretarial Auditors of the Company for a term of five
consecutive years, commencing from financial year 2026-27 till financial year 2030-31
at such remuneration and on such terms and conditions as may be determined by the
Board of Directors (including its committees thereof), and to avail any other services,
certificates, or reports as may be permissible under applicable laws;
RESOLVED FURTHER THAT the Board (including its Committee thereof) and/or any
person authorised by the Board, be and is hereby authorised, severally, to settle any
question, difficulty or doubt, that may arise in giving effect to this resolution and to do
all such acts, deeds, matters and things, as may be considered necessary, desirable and
expedient to give effect to this Resolution and/or otherwise considered by them to be in
the best interest of the Company."
4. Appointment of Mr Paresh Dhoti as an Independent Director
To consider and if thought fit, to pass, with or without modification(s), the following
resolution as a Special Resolution:
“RESOLVED THAT pursuant to the provisions of sections 149, 150, 152 read with
Schedule IV and other applicable provisions of the Companies Act, 2013 (“the Act”), the
Companies (Appointment and Qualifications of Directors) Rules, 2014 and Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,
2015 [including any statutory modification(s) or amendment(s) thereto or re-enactment(s)
thereof for the time being in force], Mr. Paresh Dhoti (DIN: 10387032), who was appointed
as an Additional Director (Independent and Non-Executive) of the Company, with effect
from 14.08.2026 under section 161 of the Act and the Articles of Association of the
Company and who holds office upto the date of this Annual General Meeting of the
Company, and who qualifies for being appointed as an Independent Director and who has
submitted a declaration that he meets the criteria of independence under Section 149(6)
of the Act and Regulation 16(1)(b) of the Listing Regulations and is eligible for appointment
under the provisions of the Act, the Rules made thereunder and the Listing Regulations,
and in respect of whom the Company has received a Notice in writing from a Member
under section 160 of the Act, proposing his candidature for the office of Director of the
Company, being so eligible, be appointed as an Independent Director of the Company, not
liable to retire by rotation, to hold office for a term of 5 (five) consecutive years commencing
from 14.08.2026 to 13.08.2031 (both days inclusive).”
5. Appointment of Mrs Disha Bharpoda as Independent Director
To consider and if thought fit, to pass, with or without modification(s), the following
resolution as a Special Resolution:
“RESOLVED THAT pursuant to the provisions of sections 149, 150, 152 read with
Schedule IV and other applicable provisions of the Companies Act, 2013 (“the Act”), the
Companies (Appointment and Qualifications of Directors) Rules, 2014 and Securities and
Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,
2015 [including any statutory modification(s) or amendment(s) thereto or re-enactment(s)
thereof for the time being in force], Mrs. Disha Bharpoda (DIN: 11897794), who was
appointed as an Additional Director (Independent and Non-Executive) of the Company,
with effect from 24.08.2026 under section 161 of the Act and the Articles of Association of
the Company and who holds office upto the date of this Annual General Meeting of the
Company, and who qualifies for being appointed as an Independent Director and who has
submitted a declaration that he meets the criteria of independence under Section 149(6)
of the Act and Regulation 16(1)(b) of the Listing Regulations and is eligible for appointment
under the provisions of the Act, the Rules made thereunder and the Listing Regulations,
and in respect of whom the Company has received a Notice in writing from a Member
under section 160 of the Act, proposing his candidature for the office of Director of the
Company, being so eligible, be appointed as an Independent Director of the Company, not
liable to retire by rotation, to hold office for a term of 5 (five) consecutive years commencing
from 24.08.2026 to 23.08.2031 (both days inclusive).”
6. Approval of Revision in Remuneration of Managing Director
To consider and if thought fit, to pass, with or without modification(s), the following
resolution as Special Resolution: -
“RESOLVED THAT pursuant to the provisions of Sections 196, 197, 198 and other
applicable provisions, if any, of the Companies Act, 2013 (“Act”), read with Schedule V to
the Act and the Companies (Appointment and Remuneration of Managerial Personnel)
Rules, 2014, as amended from time to time, and the applicable provisions of the Securities
and Exchange Board of India (Listing Obligations and D
[Showing first 8,000 characters — download PDF for full document]